Docoh
Loading...

HROW Harrow Health

APP
Utility
Epinephrine-based Ophthalmic Compositions for Intraocular Administration and Methods for Fabricating Thereof
9 Sep 21
Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator.
John Scott Karolchyk, Mark L. Baum
Filed: 25 May 21
GRANT
Utility
Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
29 Jun 21
Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator.
John Scott Karolchyk, Mark L. Baum
Filed: 25 Aug 16
GRANT
Utility
Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
4 May 21
Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator.
John Scott Karolchyk, Mark L. Baum
Filed: 3 Oct 14
APP
Utility
Pharmaceutical Compositions Comprising Heparinoids and Methods for Preparing Thereof
11 Mar 21
Pharmaceutical compositions are described herein, among others, the compositions comprising anhydrous suspensions of a therapeutically effective quantity of a heparinoid, or a derivative or analog thereof, and to methods of preparing and using such compositions.
Dennis Elias Saadeh
Filed: 1 Sep 20
APP
Utility
Pharmaceutical Compositions for Treating Presbyopia and Methods for Fabricating Thereof
11 Nov 20
Pharmaceutical compositions for treating presbyopia are described, the compositions comprising choline esterase inhibitor(s) and several other components such as α-1-adrenergic antagonist(s), non-steroid anti-inflammatory drug(s), and/or adrenergic antagonist(s).
Dennis Elias Saadeh
Filed: 23 Apr 20
APP
Utility
Pharmaceutical Formulations for the Treatment of Dry Eye and Methods for Fabricating and Using Thereof
26 Aug 20
Methods and kits for improving tear production are described, along with topical pharmaceutical compositions.
John Scott Karolchyk, John P. Saharek
Filed: 10 May 20
APP
Utility
Pyrimethamine-based Pharmaceutical Compositions and Methods for Fabricating Thereof
5 Aug 20
Pharmaceutical compositions that include aqueous suspensions of therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein.
Dennis Elias Saadeh
Filed: 19 Apr 20
GRANT
Utility
Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof
29 Jun 20
Methods and kits for improving tear production are described, along with topical pharmaceutical compositions.
John Scott Karolchyk, John P. Saharek
Filed: 25 Jul 19
GRANT
Utility
Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof
25 May 20
Pharmaceutical compositions that include aqueous suspensions of a therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein.
Dennis Elias Saadeh, Annette Marleau, Thomas Ichim
Filed: 5 Jun 19
APP
Utility
Pharmaceutical Compositions Comprising Gels and Methods for Fabricating Thereof
20 May 20
Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel.
John Scott Karolchyk, Dennis Elias Saadeh
Filed: 26 Jan 20
APP
Utility
Adrenocorticotropic Hormone-based Pharmaceutical Formulations and Methods for Fabricating and Using Thereof
20 May 20
Pharmaceutical compositions for treating, mitigating or preventing autoimmune diseases and associated conditions are described herein.
Dennis Elias Saadeh, Mark L. Baum
Filed: 27 Jan 20
APP
Utility
Pharmaceutical Compositions for Prevention or Treatment of Cytokine Release Syndrome
1 Apr 20
Pharmaceutical compositions and methods for preventing, treating, or alleviating cytokine release syndrome are described, the compositions comprising pentoxifylline and a pharmaceutically acceptable carrier.
Annette Marleau, Thomas Ichim, Dennis Elias Saadeh
Filed: 24 Sep 19
APP
Utility
Pyrimethamine-based Pharmaceutical Compositions and Methods for Fabricating Thereof
11 Dec 19
Pharmaceutical compositions that include aqueous suspensions of a therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein.
Dennis Elias Saadeh, Annette Marleau, Thomas Ichim
Filed: 5 Jun 19
GRANT
Utility
Anti-fungal compositions for treating nails and methods for fabricating and using thereof
30 Sep 19
Pharmaceutical compositions for treating, mitigating or preventing fungal nail diseases, disorders or pathologies are described, the compositions comprising at least one functionalized allylamine compound, at least one functionalized triazole compound, and at least one functionalized imidazole compound.
Dennis Elias Saadeh
Filed: 2 Jul 18
  • 1
Patents are sorted by USPTO publication date, most recent first